Barrington Research Maintains Outperform on Concentrix, Maintains $62 Price Target

Benzinga · 11/20/2025 13:16
Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:CNXC) with a Outperform and maintains $62 price target.